EpistrySign in
LimitedMetadata only — full assessment not yet run

Promising new drugs and therapeutic approaches for treatment of ovarian cancer—targeting the hallmarks of cancer

Julia S. Hillmann, Nicolaì Maass, Dirk Bauerschlag, Inken Flörkemeier · BMC Medicine · 2025

DOI 10.1186/s12916-024-03826-w

Why this label

  • Metadata only — full assessment not yet run.

The Paper Scorecard

  • Standingclear
    • No retraction on record (OpenAlex metadata as of 2026-08-23).
  • Designjournal article
    • Journal article (BMC Medicine). Study design detail comes from the methodology read, not metadata.
  • Executionnot assessed
    • Metadata only — full assessment not yet run.
  • Corroborationcited
    • Cited by 33 works (OpenAlex citation count).
  • Provenanceidentified
    • Published in BMC Medicine.
    • Publisher: BioMed Central.
    • ISSN 1741-7015.
    • The journal is listed in DOAJ.
    • Open-access status: gold.
Assessed by Epistry · metadata as of August 23, 2026
Promising new drugs and therapeutic approaches for treatment of ovari… — Epistry